Name
Kryptos Biotechnologies
Company Description
Kryptos Biotechnologies is developing Kuick, a rapid, accurate, easy-to-use and affordable molecular diagnostic system for point-of-care testing. The system uses proprietary Ultrafast Photonic PCR technology combined with sold-phase extraction in the sample preparation. The system ensures the best-in-class performance while providing test results on time.
The development of the system is completed and ready for validation study or clinical study.
Website
https://kryptosbio.com/
Product Categories (10)
DNA/RNA Based Systems, Microfluidics
Included In the Export Interest Directory
Yes
Business Needs
Direct Sales, Distributor/Agent/Representative, Investor, Joint Ventures, Licensing Agreements
Phone
267-271-5511
Address
3423 Investment Blvd. Suite 6
Hayward, CA 94545
United States

Listings

Relevance
Kryptos Biotechnologies Gets $1.2M Grant From RIGHT Foundation for Rapid STI Test
#3622
Kryptos Biotechnologies
Kryptos Raises $10 Million in Series A Financing for Clinical Studies & FDA Approval for Molecular Diagnostics System
#3622
Kryptos Biotechnologies